FLSW

Franklin FTSE Switzerland ETF

OtherPSEFranklin ETF
$43.14
$-0.50 (-1.14%)
Delayed ≥20 min · Sep 2, 2026

Key Statistics

Net Assets (AUM)
$81.97M
Expense Ratio
See prospectus
Previous Close
$43.14
Day Range
- – -
52-Week Range
$37.31 – $45.33
Volume
12.54K
Avg Vol (50D)
9.29K
Beta
0.76

Historical Performance

1M
-1.68%
3M
+2.76%
6M
+2.39%
YTD
+6.28%
1Y
+14.90%
3Y
+46.07%
5Y
+37.39%

Total return including reinvested distributions, from adjusted closing prices.

Price History

Price history is being compiled for this fund.

Top Holdings

NOVN Novartis AG 14.09%
ROP Roche Holding AG 13.43%
NESN NESTLE' CAPITAL MARKETS SA 12.28%
ABBN ABB Ltd. 6.13%
UBSG UBS Group AG 4.67%
ZURN Zurich Insurance Group AG 4.25%
CFR Compagnie Financiere Richemont Sa 3.85%
SREN Swiss RE AG 2.73%
LONN Lonza Group AG 2.56%
HOLN Holcim AG 2.33%
ALC Alcon AG 2.16%
GALD Galderma Group AG 2.08%
SDZ Sandoz Group AG 1.88%
SLHN Swiss Life Holding AG 1.81%
LISP Chocoladefabriken Lindt & Spruengli AG 1.73%
AMRZ Amrize Ltd. 1.60%
SIKA Sika AG 1.53%
GIVN Givaudan SA 1.51%
PGHN Partners Group Holding AG 1.34%
GEBN Geberit AG 1.29%
SCMN Swisscom AG 1.25%
HBAN Helvetia Baloise Holding AG 1.16%
SGSN SGS SA 1.03%
VACN VAT Group AG 0.97%
BAER Julius Baer Group AG 0.88%

Top 25 holdings as of Mar 31, 2026 · source: SEC N-PORT. Full holdings & prospectus →

About FLSW

Under normal market conditions,the Fund invests at least 80% of its assets in the component securities of the FTSE Switzerland CappedIndex and in depositary receipts representing such securities. The FTSE Switzerland Capped Index is afree float-adjusted market capitalization weighted index maintained and calculated by FTSE Russell witha capping methodology applied quarterly to issuer weights so that no single issuer of a component exceeds25% of the FTSE Switzerland Capped Index weight, and all issuers with weights above 5% do not cumulativelyexceed 50% of the FTSE Switzerland Capped Index’s weight. The FTSE Switzerland Capped Index isbased on the FTSE Switzerland Index and is designed to measure the performance of Swiss large- and mid-capitalizationstocks. FTSE Russell determines eligible securities for the FTSE Switzerland Capped Index based on measuressuch as the company’s place of incorporation, listing country, investor protection regulationspresent in the country of incorporation, tax domicile, location of headquarters/factors of productionand currency of denomination. As of May 31, 2025, the FTSE Switzerland Capped Index was comprised of52 securities with capitalizations ranging from $1.79 billion to $274.64 billion.The Fund, using a “passive”or indexing investment approach, seeks investment results that closely correspond, before fees and expenses,to the performance of the FTSE Switzerland Capped Index. The Fund may use either a replication strategyor representative sampling strategy. Under a replication strategy, the Fund will replicate the componentsecurities of the FTSE Switzerland Capped Index as closely as possible (i.e., invest in all of the componentsecurities in their respective weightings in the FTSE Switzerland Capped Index). However, under variouscircumstances, it may not be possible or practicable to replicate the FTSE Switzerland Capped Index.In these circumstances, the Fund may use a “representative sampling” strategy whereby theFund would invest in what it believes to be a representative sample of the component securities of theFTSE Switzerland Capped Index, but may not track the FTSE Switzerland Capped Index with the same degreeof accuracy as would an investment vehicle replicating the entire FTSE Switzerland Capped Index. Underthe representative sampling technique,the investment manager will select securities that collectively have an investment profile similar tothat of the FTSE Switzerland Capped Index, including securities that resemble those included in the FTSESwitzerland Capped Index in terms of risk factors, performance attributes and other characteristics,such as market capitalization and industry weightings.The Fund may invest in equity futures (includingequity index futures) and equity total return swaps to provide additional opportunities to add valueand better track the performance of the Fund’s Underlying Index, such as to equitize cash and accruedincome, simulate investments in the Underlying Index, facilitate trading or minimize transaction costs.TheFund may enter into foreign currency forward contracts and/or currency futures contracts to provide theFund with additional opportunities to add value and better track the performance of the Fund’sUnderlying Index, such as by facilitating local securities settlements or protecting against currencyexposure in connection with distributions to Fund shareholders.The Fund intends to bediversified in approximately the same proportion as the FTSE Switzerland Capped Index is diversified.The Fund may become “non-diversified,” as defined in the 1940 Act, solely as a result ofa change in relative market capitalization or index weighting of one or more constituents of the FTSESwitzerland Capped Index. A “non-diversified” fund generally invests a greater proportionof its assets in the securities of one or more issuers and invests overall in a smaller number of issuersthan a diversified fund. Shareholder approval will not be sought if the Fund becomes non-diversifieddue solely to a change in the relative market capitalization or index weighting of one or more constituentsof the FTSE Switzerland Capped Index.The Fund will concentrate its investments (i.e., hold 25%or more of its net assets) in a particular industry or group of industries to approximately the sameextent that the FTSE Switzerland Capped Index is concentrated. As of May 31, 2025, the FTSE SwitzerlandCapped Index was concentrated in the pharmaceutical industry.

Data for FLSW is aggregated from third-party providers (Tiingo, Nasdaq, Finnhub) and SEC filings, may be delayed at least 20 minutes, and may be incomplete or contain errors. Nothing here is investment advice. Verify with the official prospectus before investing.